Skip to main content
HABA LABORATORIES, INC. logo

HABA LABORATORIES, INC. — Investor Relations & Filings

Ticker · 4925 ISIN · JP3765130004 T Manufacturing
Open in API
Filings indexed 66 across all filing types
Latest filing 2023-02-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4925

About HABA LABORATORIES, INC.

http://www.haba.com/

HABA LABORATORIES, INC. is a company that develops, manufactures, and distributes natural cosmetics, quasi-drugs, and nutritional supplements. The company's product line includes skincare, hair care, and body care items. Its core philosophy, reflected in the name HABA (an acronym for "Health Aid, Beauty Aid"), is to create additive-free products that maximize the skin's natural healing power by providing only essential ingredients. The company sells its products through multiple channels, including online shopping, direct retail stores, and wholesale distribution to drug and variety stores in Japan and internationally.

Recent filings

Filing Released Lang Actions
四半期報告書－第40期第3四半期(2022/10/01－2022/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for HABA Laboratories, Inc. covering the third quarter of the fiscal year ending March 31, 2023. It contains detailed financial statements, management analysis, and auditor review information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-02-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan. This is a mandatory regulatory filing that accompanies a quarterly report to confirm the accuracy of the financial statements. Since it is a specific regulatory filing required by law and does not constitute the quarterly report itself, nor is it a mere announcement of a report, it falls under the general regulatory filings category.
2022-11-14 Japanese
四半期報告書－第40期第2四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for HABA Laboratories, Inc. covering the second quarter of the fiscal year ending March 31, 2023. It contains detailed financial statements, including the balance sheet, income statement, and cash flow analysis, as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2023
2022-11-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the First Quarter Report (Dai-ichi shihanki hokokusho). While it references the quarterly report, this specific document is a formal regulatory filing confirming the accuracy of the financial statements for the period ending June 30, 2022. Since it is a formal regulatory filing required by law and does not fit into the specific categories of the report itself or a simple announcement, it is classified as a Regulatory Filing.
2022-08-15 Japanese
四半期報告書－第40期第1四半期(令和4年4月1日－令和4年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement for the first quarter of the 40th fiscal year (April 1, 2022, to June 30, 2022). As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. Q1 2023
2022-08-15 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory document filed alongside the Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a regulatory filing required by the Financial Services Agency (Kanto Local Finance Bureau) and does not fit into the specific categories for financial reports or announcements, it is classified as a Regulatory Filing (RNS). FY 2022
2022-06-20 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.